Schisandra

Adaptogenic berry from Chinese, Russian, Korean traditional medicine — the "five-flavor berry" (sweet, sour, salty, bitter, pungent). Active constituents are lignans (schisandrins A, B, C; schizandrins; gomisins). Three primary use cases: (1) adaptogenic stress/fatigue support, (2) hepatoprotection, (3) cognitive endurance under physical load. Major caveat: schisandra is a known CYP3A4 inducer — can lower the plasma levels of medications metabolized by CYP3A4 (large list including statins, immunosuppressants, oral contraceptives, some antivirals). For Dylan: OPTIONAL-ADD low priority — V4 already covers liver support (NAC) and stress (rhodiola). Useful as targeted hepatoprotectant if ALT/AST flag in June bloodwork.

Schisandra chinensis is a vining shrub of the Schisandraceae family, native to Northeast China, Korea, and Russia's Far East. Berry extracts contain >40 dibenzocyclooctadiene lignans plus essential oils, organic acids, and polysaccharides. Standardization typically targets schisandrin A and schizandrin (sometimes labeled "schisandrol A").

Mechanism dimensions:

1. Hepatoprotection via Nrf2 + GST induction:

• Schisandrin B is a potent Nrf2 activator — induces glutathione S-transferase (GST), heme oxygenase-1 (HO-1), and other phase II detoxification enzymes
• Reduces CCl4-, acetaminophen-, and ethanol-induced liver injury in animal models robustly
• Most-cited human use is for chronic hepatitis B/C adjunct therapy in Chinese/Korean clinical practice; reduces ALT/AST in those populations

2. CYP3A4 induction (the major stack-conflict warning):

• Schisandra extracts (especially schisandrin and schizandrins) are moderate-to-strong inducers of CYP3A4
• Reduces plasma levels of: statins, calcineurin inhibitors (tacrolimus, cyclosporine), oral contraceptives, midazolam, many antivirals
• Mai 2004 study showed schisandra co-administration reduced midazolam AUC by ~30%
• This is dose-dependent; lower doses or short-term use less impactful

3. Adaptogenic / HPA-axis modulation:

• Russian classical-adaptogen designation alongside rhodiola and eleuthero
• Animal data: improves swimming endurance, reduces stress-induced gastric ulcer, modulates cortisol response to stress
• Human data: Soviet/Russian endurance trials in the 1970s-80s (variable methodology); modern Western trials sparse

4. Mild monoamine effects:

• Schisandrin B has mild MAO-A inhibitory activity in vitro
• May contribute to mood-supportive effect anecdotally reported

5. Cognitive / cerebrovascular:

• Limited direct cognitive trials
• Animal data: schisandrin B improves spatial memory in scopolamine-induced impairment; reduces oxidative damage in hippocampus
• Cerebrovascular: mild vasodilation reported